Clinical trials
Phase 1/2 Glioma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Basilea Pharmaceutica | 1 |
| Blueprint Medicines Corporation | 1 |
| Boston Scientific Corporation | 1 |
| Bristol-Myers Squibb | 1 |
| Hoffmann-La Roche | 1 |
| INSYS Therapeutics Inc | 1 |
| Universitätsmedizin Mannheim | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 12 |
| Glioblastoma | 5 |
| Astrocytoma | 3 |
| Medulloblastoma | 3 |
| Neoplasms | 3 |
| Neuroblastoma | 3 |
| Recurrence | 3 |
| Sarcoma, Ewing | 3 |
| Brain Neoplasms | 2 |
| Central Nervous System Neoplasms | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.